• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Olanzapine-Induced Malignant Neuroleptic Syndrome.奥氮平所致恶性抗精神病综合征
Turk J Anaesthesiol Reanim. 2014 Oct;42(5):288-91. doi: 10.5152/TJAR.2014.46704. Epub 2014 Jul 9.
2
Olanzapine-Induced Neuroleptic Malignant Syndrome.奥氮平所致的抗精神病药恶性综合征
Iran J Med Sci. 2017 May;42(3):306-309.
3
A Neuroleptic Malignant Syndrome Without Rigidity.一种无强直的抗精神病药恶性综合征。
Psychiatry Investig. 2018 Feb;15(2):226-229. doi: 10.30773/pi.2017.06.05. Epub 2017 Dec 14.
4
Atypical Neuroleptic Malignant Syndrome Precipitated by Clozapine and Quetiapine Overdose: A Diagnostic Challenge.氯氮平和喹硫平过量引发的非典型抗精神病药恶性综合征:一项诊断挑战。
Innov Clin Neurosci. 2018 Aug 1;15(7-8):20-22. eCollection 2018 Jul-Aug.
5
[Neuroleptic malignant syndrome after treatment with olanzapine].奥氮平治疗后发生的神经阻滞剂恶性综合征
Ugeskr Laeger. 1999 Mar 8;161(10):1424-5.
6
[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].[病例报告:抗精神病药恶性综合征及诊断难点]
Encephale. 2016 Jun;42(3):277-80. doi: 10.1016/j.encep.2016.01.001. Epub 2016 Feb 26.
7
Neuroleptic malignant syndrome due to olanzapine.奥氮平所致的抗精神病药恶性综合征
Psychopharmacol Bull. 2001 Summer;35(3):49-54.
8
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].[抗精神病药恶性综合征与非典型抗精神病药物:简要综述]
Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.
9
Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.在接受利伐斯的明联合治疗的患者中出现的奥氮平相关性抗精神病药恶性综合征。
Pharmacotherapy. 2008 Mar;28(3):403-5. doi: 10.1592/phco.28.3.403.
10
Atypical neuroleptic malignant syndrome associated with olanzapine.与奥氮平相关的非典型抗精神病药恶性综合征。
Pharmacotherapy. 2002 May;22(5):641-4. doi: 10.1592/phco.22.8.641.33211.

引用本文的文献

1
Neuroleptic Malignant Syndrome in a Patient With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Case Report and Review of Related Literature.一名抗N-甲基-D-天冬氨酸受体脑炎患者的抗精神病药恶性综合征:病例报告及相关文献综述
Neurohospitalist. 2022 Jan;12(1):80-85. doi: 10.1177/19418744211002978. Epub 2021 Mar 19.
2
[Prolonged neuroleptic malignant syndrome after Haloperidol injection].[氟哌啶醇注射后出现的持续性神经阻滞剂恶性综合征]
Med Klin Intensivmed Notfmed. 2018 Apr;113(3):212-216. doi: 10.1007/s00063-017-0325-6. Epub 2017 Jul 27.

本文引用的文献

1
Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine.奥氮平和氯丙嗪急性过量服用后发生的抗精神病药恶性综合征。
J Med Toxicol. 2009 Mar;5(1):27-31. doi: 10.1007/BF03160978.
2
Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.奥氮平诱发的偏执型精神分裂症患者的抗精神病药恶性综合征
Psychiatry Clin Neurosci. 2009 Feb;63(1):119-21. doi: 10.1111/j.1440-1819.2008.01894.x. Epub 2008 Dec 1.
3
Atypical neuroleptic malignant syndrome caused by olanzapine.奥氮平引起的非典型抗精神病药恶性综合征。
Acta Psychiatr Scand. 2005 Sep;112(3):238-40; discussion 240. doi: 10.1111/j.1600-0447.2005.00578.x.
4
Neuropsychiatric sequelae of neuroleptic malignant syndrome.
Clin Neuropharmacol. 2005 Jul-Aug;28(4):197-204. doi: 10.1097/01.wnf.0000172079.80795.5f.
5
Olanzapine induced "typical" neuroleptic malignant syndrome.
J Clin Psychopharmacol. 2003 Feb;23(1):101-2. doi: 10.1097/00004714-200302000-00016.
6
The neuroleptic malignant and serotonin syndromes.抗精神病药恶性综合征和血清素综合征。
Emerg Med Clin North Am. 2000 May;18(2):317-25, x. doi: 10.1016/s0733-8627(05)70127-9.
7
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Med Clin North Am. 1993 Jan;77(1):185-202. doi: 10.1016/s0025-7125(16)30278-4.
8
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Am J Psychiatry. 1985 Oct;142(10):1137-45. doi: 10.1176/ajp.142.10.1137.
9
Risk factors for neuroleptic malignant syndrome. A case-control study.抗精神病药恶性综合征的危险因素。一项病例对照研究。
Arch Gen Psychiatry. 1989 Oct;46(10):914-8. doi: 10.1001/archpsyc.1989.01810100056011.
10
A prospective analysis of 24 episodes of neuroleptic malignant syndrome.对24例抗精神病药恶性综合征发作的前瞻性分析。
Am J Psychiatry. 1989 Jun;146(6):717-25. doi: 10.1176/ajp.146.6.717.

奥氮平所致恶性抗精神病综合征

Olanzapine-Induced Malignant Neuroleptic Syndrome.

作者信息

Sarıtaş Tuba Berra, Çankaya Barış, Yosunkaya Alper

机构信息

Department of Anaesthesiology and Reanimation, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey.

Clinic of Anaesthesiology and Reanimation, Dr. İ. Şevki Atasagun State Hospital, Nevşehir, Turkey.

出版信息

Turk J Anaesthesiol Reanim. 2014 Oct;42(5):288-91. doi: 10.5152/TJAR.2014.46704. Epub 2014 Jul 9.

DOI:10.5152/TJAR.2014.46704
PMID:27366439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4894178/
Abstract

Neuroleptic malignant syndrome (NMS), caused by antipsychotic therapy, shows itself with mental status alteration, high fever, autonomic dysfunction, and muscle rigidity. It is a rare idiosyncratic reaction with mortality risk. The etiology is still unknown. NMS-related mortality and morbidity can be decreased by cessation of the used drug and aggressive treatment. Olanzapine is a thienobenzodiazepine, a member of atypical antipsychotic drugs; its structure and effects on neurotransmitters resemble clozapine. Here we report a case of bipolar disorder receiving olanzapine therapy for 10 years, who developed NMS without rigidity. We emphasized the importance of early hydration and hemodiafiltration therapy.

摘要

抗精神病药物治疗引起的神经阻滞剂恶性综合征(NMS)表现为精神状态改变、高热、自主神经功能障碍和肌肉强直。它是一种罕见的特异反应,有死亡风险。病因仍不清楚。停用所用药物并积极治疗可降低与NMS相关的死亡率和发病率。奥氮平是一种噻吩并苯二氮䓬类药物,属于非典型抗精神病药物;其结构和对神经递质的作用类似于氯氮平。在此,我们报告一例双相情感障碍患者,接受奥氮平治疗10年,发生了无强直的NMS。我们强调了早期补液和血液透析滤过治疗的重要性。